Genetic insights into the pathobiology of age-related macular degeneration

International Ophthalmology Clinics

Volumn 47, Issue 1, 2007, Pages 1-14

  Mullins, Robert F ^a  

^a 4135E MERF ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; COMPLEMENT FACTOR H; CX3C CHEMOKINE; FIBULIN 5; HLA B ANTIGEN; IMATINIB;

BRUCH MEMBRANE; CHRONIC MYELOID LEUKEMIA; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; HUMAN; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; STARGARDT DISEASE;

ALLELES; ATP-BINDING CASSETTE TRANSPORTERS; DNA; EXTRACELLULAR MATRIX PROTEINS; EYE PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MACULAR DEGENERATION; MEMBRANE PROTEINS; MUTATION; PIGMENT EPITHELIUM OF EYE; POLYMORPHISM, GENETIC; RISK FACTORS; ROD OUTER SEGMENTS;

EID: 33846424317     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e31802bd3e6     Document Type: Review

References (78)

1. Nussbaum R, McInnes R, Willard H. Thompson and Thompson Genetics in Medicine. 6th ed. Philadelphia, PA: Saunders; 2004.
2. Doyne RW. Peculiar condition of choroiditis occurring in several members of the same family. Trans Ophthalmol Soc UK. 1899;19:71-74.
3. Gass J. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973;90:206-217.
4. Klein M, Mauldin W, Stoumbos V. Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol. 1994;112:932-937.
5. Klaver CCW, Wolfs RCW, Assink JJM, et al. Genetic risk of age-related maculopathy: population-based familial aggregation study. Arch Ophthalmol. 1998;116:1646-1651.
6. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genetics. 2001;28:92-95.
7. O'Brien SG, Guilhot F, Larson RA, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003;348:994-1004.
8. Weber B, Vogt G, Pruett R, et al. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genetics. 1994;8:352-356.
9. Gorin MB, Jackson KE, Ferrell RE, et al. A peripherin/retinal degeneration slow mutation (Pro-210-Arg) associated with macular and peripheral retinal degeneration. Ophthalmology. 1995;102:246-255.
10. Allikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genetics. 1997;15:236-246.
11. Stone E, Lotery A, Munier F, et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genetics. 1999;22:199-202.
12. Zhang K, Kniazeva M, Han M, et al. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genetics. 2001;27:89-93.
13. Stone E, Sheffield V, Hageman G. Molecular genetics of age-related macular degeneration. Hum Mol Genetics. 2001;10:2285-2292.
14. Klaver CC, Allikmets R. Genetics of macular dystrophies and implications for age-related macular degeneration. Dev Ophthalmol. 2003;37:155-169.
15. Weng J, Mata N, Azarian S, et al. Insights into the function of rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell. 1999;98:13-23.
16. Shroyer NF, Lewis RA, Yatsenko AN, et al. Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration. Hum Mol Genetics. 2001;10:2671-2678.
17. Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genetics. 2000;67:487-491.
18. Stone EM, Webster AR, Vandenburgh K, et al. Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration. Nat Genetics. 1998;20:328-329.
19. De La Paz M, Guy V, Abou-Donia S, et al. Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration. Ophthalmology. 1999;106:1531-1536.
20. Rivera A, White K, Stohr H, et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genetics. 2000;67:800-813.
21. Bernstein PS, Tammur J, Singh N, et al. Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. Invest Ophthalmol Vis Sci. 2001;42:3331-3336.
22. Karan G, Yang Z, Zhang K. Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability. Mol Vis. 2004;10:248-253.
23. Conley YP, Thalamuthu A, Jakobsdottir J, et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genetics. 2005;14:1991-2002.
24. Stone E, Braun T, Russell S, et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med. 2004;351:346-353.
25. Schultz D, Klein M, Humpert A, et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genetics. 2003;12:3315-3323.
26. Ayyagari R, Zhang K, Hutchinson A, et al. Evaluation of the ELOVL4 gene in patients with age-related macular degeneration. Ophthalmic Genetics. 2001;22:233-239.
27. DeLaPaz MA, Pericak-Vance MA, Lennon F, et al. Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1997;38:1060-1065.
28. Guymer RH, McNeil R, Cain M, et al. Analysis of the Arg345Trp disease-associated allele of the EFEMP1 gene in individuals with early onset drusen or familial age-related macular degeneration. Clin Exp Ophthalmol. 2002;30:419-423.
29. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Ann Rev Neurosci. 1996;19:53-77.
30. Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genetics. 1998;63:200-206.
31. Zareparsi S, Reddick AC, Branham KE, et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci. 2004;45:1306-1310.
32. Baird PN, Richardson AJ, Robman LD, et al. Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD). Hum Mutat. 2006;27:337-342.
33. Wong TY, Shankar A, Klein R, et al. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study. Ophthalmology. 2006;113:255-259.
34. Nussenblatt R, Mittal K, Ryan S, et al. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol. 1982;94:147-158.
35. Baarsma GS, Priem HA, Kijlstra A. Association of birdshot retinochoroidopathy and HLA-A29 antigen. Curr Eye Res. 1990;9(suppl):63-68.
36. Goverdhan S, Mullins R, Howell W, et al. Association of HLA class I and class II polymorphisms with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2005;46:1726-1734.
37. Tuo J, Smith BC, Bojanowski CM, et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J. 2004;18:1297-1299.
38. Klein R, Zeiss C, Chew E, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389.
39. Edwards A, Ritter R, Abel K, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.
40. Haines J, Hauser M, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.
41. Hageman G, Anderson D, Johnson L, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227-7232.
42. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genetics. 2005;14:3227-3236.
43. Magnusson KP, Duan S, Sigurdsson H, et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med. 2006;3:e5.
44. Sepp T, Khan JC, Thurlby DA, et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci. 2006;47:536-540.
45. Souied EH, Leveziel N, Richard F, et al. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis. 2005;11:1135-1140.
46. Okamoto H, Umeda S, Obazawa M, et al. Complement factor H polymorphisms in Japanese population with age-related macular degeneration. Mol Vis. 2006;12:156-158.
47. Grassi M, Fingert J, Sheetz T, et al. Ethnic variation in AMD-associated complement factor H polymorphism Tyr402His. Hum Mutat. 2006;27:921-925.
48. Fisher SA, Abecasis GR, Yashar BM, et al. Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genetics. 2005;14:2257-2264.
49. Jakobsdottir J, Conley YP, Weeks DE, et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genetics. 2005;77:389-407.
50. Schmidt S, Hauser MA, Scott WK, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genetics. 2006;78:852-864.
51. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004;122:598-614.
52. Starita C, Hussain A, Pagliarini S, et al. Hydrodynamics of ageing Bruch's membrane: implications for macular disease. Exp Eye Res. 1996;62:565-572.
53. Ishibashi T, Murata T, Hangai M, et al. Advanced glycation end products in age-related macular degeneration. Arch Ophthalmol. 1998;116:1629-1632.
54. Handa J, Verzijl N, Matsunaga H, et al. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci. 1999;40:775-779.
55. Curcio C, Millican C, Bailey T, et al. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001;42:265-274.
56. Mullins R, Anderson D, Russell S, et al. Ocular drusen contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14:835-846.
57. Malek G, LI C, Guidry C, et al. Apolipoprotein B in cholesterol- containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol. 2003;162:413-425.
58. Dithmar S, Curcio CA, Le NA, et al. Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. Invest Ophthalmol Vis Sci. 2000;41:2035-2042.
59. Malek G, Johnson LV, Mace BE, et al. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci USA. 2005;102:11900-11905.
60. Green W, McDonnell P, Yeo J. Pathologic features of senile macular degeneration. Ophthalmology. 1985;92:615-627.
61. Spraul C, Grossniklaus H. Characteristics of drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch Ophthalmol. 1997;115:267-273.
62. Curcio C, Millican C. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol. 1999;117:329-339.
63. Chong N, Keonin J, Luthert P, et al. Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to distribution of lesions associated with AMD. Am J Pathol. 2005;166:241-251.
64. Yanagisawa H, Davis EC, Starcher BC, et al. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature. 2002;415:168-171.
65. Lotery AJ, Baas D, Ridley C, et al. Reduced secretion of fibulin 5 in age-related macular degeneration and cutis laxa. Hum Mutat. 2006;27:568-574.
66. Hageman G, Luthert P, Chong N, et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705-732.
67. Penfold P, Madigan M, Gillies M, et al. Immunological and aetiological aspects of macular degeneration. Prog Retinal Eye Res. 2001;20:385-414.
68. Anderson D, Mullins R, Hageman G, et al. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411-431.
69. Johnson L, Leitner W, Staples M, et al. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res. 2001;73:887-896.
70. Bora P, Sohn J, Cruz J, et al. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol. 2005;174:491-497.
71. Nozaki M, Raisler BJ, Sakurai E, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA. 2006;103:2328-2333.
72. Penfold P, Killingsworth M, Sarks S. Senile macular degeneration: the involvement of immunocompetent cells. Graefe's Arch Clin Exp Ophthalmol. 1985;223:69-76.
73. Penfold P, Killingsworth M, Sarks S. Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1986;27:364-371.
74. Lopez P, Grossniklaus H, Lambert H, et al. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1991;112:647-656.
75. Grossniklaus HE, Ling JX, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis. 2002;8:119-126.
76. Chan CC, Tuo J, Bojanowski CM, et al. Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. Histol Histopathol. 2005;20:857-863.
77. Zareparsi S, Buraczynska M, Branham KE, et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genetics. 2005;14:1449-1455.
78. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genetics. 2006;38:458-462.